The mRNA Revolution Heats Up: What's Behind Moderna's Sudden Pullback? Moderna's stock price has taken a hit after skyrocketing over 5 times this year. Shares dropped from $176.
66 highs to around $148 per share as of writing. This downturn raises questions about whether the company's growth trajectory has finally peaked or if investors are simply taking a breather before the next leg up.
Over the past five years, Moderna's stock value plummeted by over 60% due in part to its failure to replicate early pandemic era success with its coronavirus vaccine.